The Brain Pacemaker Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for brain pacemakers has seen significant expansion in the recent past. The market, valued at $1.57 billion in 2024, is anticipated to increase to $1.82 billion in 2025, displaying a compound annual growth rate (CAGR) of 15.5%.
The Brain Pacemaker market is projected to increase to a value of $3.19 billion in 2029, growing at a compound annual growth rate (CAGR) of 15.1%.
Download Your Free Sample of the 2025 Brain Pacemaker Market Report and Uncover Key Trends Now!The drivers in the brain pacemaker market are:
• Increasing prevalence of Parkinson’s disease
• Continuous advancements in neuromodulation technologies
• Clinical success and regulatory approvals of brain pacemakers
• Rising knowledge and awareness of movement disorders
• Increasing healthcare expenditure
The brain pacemaker market covered in this report is segmented –
1) By Type: Single Channel, Dual Channel
2) By Application: Dystonia, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder, Parkinson's Disease, Other Applications
3) By Sales Channel: Channel Sales, Direct Sales
4) By End-User: Hospitals, Ambulatory Surgical Centers And Clinics, Other End-Users
The trends in the brain pacemaker market are:
• The industry is observing a trend of advanced targeting algorithms development.
• The development of closed-loop Deep Brain Stimulation (DBS) systems is another emerging trend.
• Integration of wireless charging capabilities in devices is becoming a popular trend.
• Advancements in minimally invasive surgical techniques and innovations in battery technology are shaping the future of the market.
The major players in the brain pacemaker market are:
• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• LivaNova PLC
• Renishaw plc
• Beijing PINS Medical Co
North America was the largest region in the brain pacemaker market in 2023